---
title: "Moderna, Inc. (MRNA.US) Q3 2021 Earnings Conference Call"
description: "Moderna, Inc. is committed to the development of transformative messenger ribonucleic acid (mRNA) therapeutics. Its product line includes preventive vaccines, c"
locale: "en"
url: "https://longbridge.com/en/lives/3632"
parent: "https://longbridge.com/en/lives.md"
category: "Earnings Call"
---

# Moderna, Inc. (MRNA.US) Q3 2021 Earnings Conference Call

**Status**: Unknown
**Category**: Earnings Call

## Description

Moderna, Inc. is committed to the development of transformative messenger ribonucleic acid (mRNA) therapeutics. Its product line includes preventive vaccines, cancer vaccines, intratumoral immunooncology, local regenerative therapy, systemic secretion therapy, and systemic intracellular therapy. The company was founded in 2010 by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien, and is headquartered in Cambridge, Massachusetts.

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.